98 related articles for article (PubMed ID: 34680387)
1. Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing.
Wessman S; Fuentes BB; Törngren T; Kvist A; Kokaraki G; Menkens H; Hjerpe E; Hugo Y; Petta TB; Borg Å; Carlson JW
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680387
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing identifies potential novel therapeutic targets in Chinese HGSOC patients.
Tao J; Sun D; Zhou H; Zhu J; Zhang X; Hou H
Pathol Res Pract; 2022 Oct; 238():154074. PubMed ID: 35988354
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma.
Nasioudis D; Latif NA; Ko EM; Cory L; Kim SH; Martin L; Simpkins F; Giuntoli R
Gynecol Oncol; 2023 Oct; 177():14-19. PubMed ID: 37611378
[TBL] [Abstract][Full Text] [Related]
4. Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.
Boscolo Bielo L; Repetto M; Crimini E; Belli C; Setola E; Parma G; Fusco N; Barberis M; Guerini Rocco E; Marra A; Colombo N; Curigliano G
Oncologist; 2024 May; ():. PubMed ID: 38716772
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing identifies
Dicks EM; Tyrer JP; Ezquina S; Jones M; Baierl J; Peng PC; Diaz M; Goode E; Winham SJ; Dörk T; Van Gorp T; De Fazio A; Bowtell D; Odunsi K; Moysich K; Pavanello M; Campbell I; Brenton JD; Ramus SJ; Gayther SA; Pharoah PDP
medRxiv; 2024 Apr; ():. PubMed ID: 38633804
[TBL] [Abstract][Full Text] [Related]
6. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial.
Banerjee S; Moore KN; Colombo N; Scambia G; Kim BG; Oaknin A; Friedlander M; Lisyanskaya A; Floquet A; Leary A; Sonke GS; Gourley C; Oza A; González-Martín A; Aghajanian C; Bradley WH; Holmes E; Lowe ES; DiSilvestro P
Lancet Oncol; 2021 Dec; 22(12):1721-1731. PubMed ID: 34715071
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Genotype-Matched Therapy for Recurrent Gynecological Cancers: A Single Institutional Experience.
Sawada K; Nakayama K; Nakamura K; Yoshimura Y; Razia S; Ishikawa M; Yamashita H; Ishibashi T; Sato S; Kyo S
Healthcare (Basel); 2021 Oct; 9(10):. PubMed ID: 34683075
[TBL] [Abstract][Full Text] [Related]
8. Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction.
Chiang YC; Lin PH; Cheng WF
Front Oncol; 2021; 11():675972. PubMed ID: 34722237
[TBL] [Abstract][Full Text] [Related]
9. Homologous recombination proficiency in ovarian and breast cancer patients.
Creeden JF; Nanavaty NS; Einloth KR; Gillman CE; Stanbery L; Hamouda DM; Dworkin L; Nemunaitis J
BMC Cancer; 2021 Oct; 21(1):1154. PubMed ID: 34711195
[TBL] [Abstract][Full Text] [Related]
10. Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy.
Lainé A; Sims TT; Le Saux O; Ray-Coquard I; Coleman RL
Curr Oncol Rep; 2021 Nov; 23(12):148. PubMed ID: 34751835
[TBL] [Abstract][Full Text] [Related]
11. Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data.
Arend RC; O'Malley DM; Banerjee S; McLaurin K; Davidson R; Long GH
Adv Ther; 2022 Jan; 39(1):328-345. PubMed ID: 34727316
[TBL] [Abstract][Full Text] [Related]
12. Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020.
Obermair A; Beale P; Scott CL; Beshay V; Kichenadasse G; Simcock B; Nicklin J; Lee YC; Cohen P; Meniawy T
J Gynecol Oncol; 2021 Nov; 32(6):e95. PubMed ID: 34708597
[TBL] [Abstract][Full Text] [Related]
13. Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis.
Witjes VM; van Bommel MHD; Ligtenberg MJL; Vos JR; Mourits MJE; Ausems MGEM; de Hullu JA; Bosse T; Hoogerbrugge N
Gynecol Oncol; 2022 Jan; 164(1):221-230. PubMed ID: 34702566
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score.
Westphalen CB; Fine AD; André F; Ganesan S; Heinemann V; Rouleau E; Turnbull C; Garcia Palacios L; Lopez JA; Sokol ES; Mateo J
Clin Cancer Res; 2022 Apr; 28(7):1412-1421. PubMed ID: 34740923
[TBL] [Abstract][Full Text] [Related]
15. Two redundant ubiquitin-dependent pathways of BRCA1 localization to DNA damage sites.
Sherker A; Chaudhary N; Adam S; Heijink AM; Noordermeer SM; Fradet-Turcotte A; Durocher D
EMBO Rep; 2021 Dec; 22(12):e53679. PubMed ID: 34726323
[TBL] [Abstract][Full Text] [Related]
16. PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations.
von Werdt A; Brandt L; Schärer OD; Rubin MA
JCO Precis Oncol; 2021; 5():. PubMed ID: 34712892
[TBL] [Abstract][Full Text] [Related]
17. Development of New Cancer Treatment by Identifying and Focusing the Genetic Mutations or Altered Expression in Gynecologic Cancers.
Tang YH; Lin CY; Lai CH
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680987
[TBL] [Abstract][Full Text] [Related]
18. WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells.
Datta A; Biswas K; Sommers JA; Thompson H; Awate S; Nicolae CM; Thakar T; Moldovan GL; Shoemaker RH; Sharan SK; Brosh RM
Nat Commun; 2021 Nov; 12(1):6561. PubMed ID: 34772932
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency.
Bajrami I; Walker C; Krastev DB; Weekes D; Song F; Wicks AJ; Alexander J; Haider S; Brough R; Pettitt SJ; Tutt ANJ; Lord CJ
Commun Biol; 2021 Nov; 4(1):1270. PubMed ID: 34750509
[TBL] [Abstract][Full Text] [Related]
20. Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma.
Akter J; Katai Y; Sultana P; Takenobu H; Haruta M; Sugino RP; Mukae K; Satoh S; Wada T; Ohira M; Ando K; Kamijo T
Oncogenesis; 2021 Nov; 10(11):73. PubMed ID: 34743173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
